Tonini G., B.C. (2006). Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. DIABETOLOGIA, 49(9), 2210-2213 [10.1007/s00125-006-0329-x].

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene

BARBETTI, FABRIZIO
2006

Pubblicato
Rilevanza internazionale
Lettera
Sì, ma tipo non specificato
Settore MED/13 - Endocrinologia
English
Con Impact Factor ISI
antidiabetic agent; glibenclamide; glipizide; insulin; sulfonylurea; clinical article; clinical trial; diabetes control; diabetes mellitus; diarrhea; gene mutation; gestational age; human; letter; missense mutation; newborn; newborn period; priority journal; Amino Acid Substitution; Blood Glucose; Child; Diabetes Mellitus; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Infant, Newborn, Diseases; Insulin; Mutation; Potassium Channels, Inwardly Rectifying; Sulfonylurea Compounds; Treatment Outcome
Tonini G., B.C. (2006). Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. DIABETOLOGIA, 49(9), 2210-2213 [10.1007/s00125-006-0329-x].
Tonini, G; Bizzarri, C; Bonfanti, R; Vanelli, M; Cerutti, F; Faleschini, E; Meschi, F; Prisco, F; Ciacco, E; Cappa, M; Torelli, C; Cauvin, V; Tumini, S; Iafusco, D; Barbetti, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/46227
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 51
social impact